In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin.

Charlaine A AventuradoJunie B BillonesRoss D VasquezAgnes L Castillo

Published in: Drug design, development and therapy (2020)

This study demonstrates the potential of syringin as an anti-angiogenic agent and elicits further investigations to establish its application in cancer suppression.

Keyphrases

papillary thyroid
human health
risk assessment
squamous cell carcinoma
lymph node metastasis